MESO
Price
$10.91
Change
-$0.01 (-0.09%)
Updated
Jun 30, 04:59 PM (EDT)
Capitalization
1.37B
58 days until earnings call
ZURA
Price
$1.04
Change
-$0.01 (-0.95%)
Updated
Jun 30, 04:59 PM (EDT)
Capitalization
64.97M
Interact to see
Advertisement

MESO vs ZURA

Header iconMESO vs ZURA Comparison
Open Charts MESO vs ZURABanner chart's image
Mesoblast
Price$10.91
Change-$0.01 (-0.09%)
Volume$500
Capitalization1.37B
Zura Bio
Price$1.04
Change-$0.01 (-0.95%)
Volume$2.38K
Capitalization64.97M
MESO vs ZURA Comparison Chart in %
Loading...
MESO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MESO vs. ZURA commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MESO is a Buy and ZURA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (MESO: $10.92 vs. ZURA: $1.05)
Brand notoriety: MESO and ZURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MESO: 82% vs. ZURA: 961%
Market capitalization -- MESO: $1.37B vs. ZURA: $64.97M
MESO [@Biotechnology] is valued at $1.37B. ZURA’s [@Biotechnology] market capitalization is $64.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MESO’s FA Score shows that 0 FA rating(s) are green whileZURA’s FA Score has 0 green FA rating(s).

  • MESO’s FA Score: 0 green, 5 red.
  • ZURA’s FA Score: 0 green, 5 red.
According to our system of comparison, ZURA is a better buy in the long-term than MESO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MESO’s TA Score shows that 4 TA indicator(s) are bullish while ZURA’s TA Score has 3 bullish TA indicator(s).

  • MESO’s TA Score: 4 bullish, 6 bearish.
  • ZURA’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, MESO is a better buy in the short-term than ZURA.

Price Growth

MESO (@Biotechnology) experienced а +4.65% price change this week, while ZURA (@Biotechnology) price change was -7.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +32.93%, and the average quarterly price growth was +6.81%.

Reported Earning Dates

MESO is expected to report earnings on Aug 27, 2025.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MESO($1.37B) has a higher market cap than ZURA($65M). MESO YTD gains are higher at: -44.848 vs. ZURA (-58.000). ZURA has higher annual earnings (EBITDA): -66.05M vs. MESO (-77.78M). ZURA has more cash in the bank: 171M vs. MESO (37.7M). MESO has higher revenues than ZURA: MESO (5.67M) vs ZURA (0).
MESOZURAMESO / ZURA
Capitalization1.37B65M2,111%
EBITDA-77.78M-66.05M118%
Gain YTD-44.848-58.00077%
P/E RatioN/A7.96-
Revenue5.67M0-
Total Cash37.7M171M22%
Total Debt126MN/A-
FUNDAMENTALS RATINGS
MESO: Fundamental Ratings
MESO
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MESOZURA
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
59%
Momentum
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
57%
MACD
ODDS (%)
Bearish Trend 4 days ago
69%
Bearish Trend 4 days ago
56%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
67%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
81%
Bullish Trend 4 days ago
43%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 11 days ago
85%
Bearish Trend 4 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
75%
Aroon
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
MESO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DLAKF8.340.44
+5.51%
Deutsche Lufthansa AG
GBCS2.200.02
+0.92%
Selectis Health,Inc.
CCYY5.700.05
+0.88%
CCCB BANCORP INC.
BGOUF2.06N/A
N/A
Bang & Olufsen AS
DUERF21.75N/A
N/A
Duerr AG

MESO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MESO has been loosely correlated with QTTB. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if MESO jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MESO
1D Price
Change %
MESO100%
+1.58%
QTTB - MESO
51%
Loosely correlated
-5.16%
ZURA - MESO
34%
Loosely correlated
-8.70%
AVTX - MESO
32%
Poorly correlated
+0.42%
PYPD - MESO
28%
Poorly correlated
-0.28%
CAPR - MESO
28%
Poorly correlated
+9.53%
More

ZURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZURA has been loosely correlated with SYRE. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ZURA jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZURA
1D Price
Change %
ZURA100%
-8.70%
SYRE - ZURA
47%
Loosely correlated
-4.99%
CCCC - ZURA
45%
Loosely correlated
-7.89%
PDSB - ZURA
43%
Loosely correlated
-2.76%
IDYA - ZURA
42%
Loosely correlated
-4.13%
NRIX - ZURA
42%
Loosely correlated
+0.17%
More